CaPPRe has published a peer reviewed research paper on Myeloma Patient Value Mapping. Using discrete choice experiments (DCEs), this study examined myeloma patients’ preferences for treatment in the UK. It set out to define the relative importance of key treatment attributes, characterise the risk-benefit trade-offs in patients’ decision-making, and to analyse the predictive power of basic demographic factors. The findings have important implications for healthcare policy decisions and could... Read more
CaPPRe has published a peer reviewed research paper on alignment of preferences in the treatment of multiple myeloma (MM). Using discrete choice experiments (DCEs), this study examined treatment preferences of people living with MM compared to the treatment preferences of other groups involved in treatment decision making, including carers, as well as physicians and nurses who treat people living with MM in Australia. This study demonstrated that not all people living with MM valued the same... Read more
CaPPRe has published a peer-reviewed research paper on patient preferences for inflammatory arthritis treatments (IA). Using discrete choice experiment methodology, the findings showed that most patients consider clinical efficacy, stopping disease progression and the risk of mild-to-moderate side effects as important treatment attributes. The findings are relevant for clinicians when prescribing treatment to patients with IA.
The paper can be accessed... Read more
CaPPRe has published a peer-reviewed research paper on patient and physician preferences for atopic dermatitis injection treatments in Japan. Using discrete choice experiment methodology, the findings showed that physicians were more likely to value the efficacy of treating rashes, whereas patients preferred add-on treatments, were against self-administering the treatment at home, and were less concerned about cost. The differing treatment preferences of physicians and patients have... Read more
During 2018 and 2019 Community and Patient Preference Research (CaPPRe) conducted research about treatment choices in advanced prostate cancer. We would like to take this opportunity to thank those who participated in the online survey. Participation was invaluable and has contributed to a greater understanding of the preferences people... Read more
CaPPRe was commissioned by Janssen to conduct a traetment preference study for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis patients. The poster is presented at the 21st Asia Pacific League of Associations for Rheumatology Congress. Click here for the poster.
CaPPRe has published a peer-reveiwed research paper on patient preferences for type 2 diabetes treatments. Using discrete choice experiment methodology, the findings showed that patients considered injection frequency, weight change and nausea to be important features of treatment. Patients were wiling to pay an additional $22.35 AUD/month for the benefits of a once-weekly injection over a twice-daily injection.
The paper is published in the open-access journal BMC Health Services... Read more
In August 2017, we conducted a community value mapping study in 500 consumers who had visited a pharmacy in the last 3 months. Participants were asked to evaluate their preferences for pharmacies offering different locations, opening hours, sevrices and cost. Results showed that there were 3 segments of consumers; those that were service driven, those that were access driven and those that were driven by loyalty. For more infromation about the study and our findings, see... Read more
In December 2017 we conducted a pilot study to understand parents'/caregivers' preferences for school canteen menus. We surveyed 416 parents/caregivers in NSW with at least one child in primary school. We presented the findings at an invitation-only economics conference with NSW Government in January 2018. To see the findings, see our infographic or ... Read more
In August 2017 we conducted a pilot study to understand the community's preferences for genetic testing. We surveyed a representative sample of 500 people across Australia and asked them to evaulate different options for genetic testing in areas of cancer, arthritis, Alzheimer's disease, bipolar disorder and multiple sclerosis. Overall, 9 in 10 people said that they would do a genetic test to find out their risk factors for certain diseases.... Read more